期刊文献+

环孢素A联合甲氨蝶呤治疗对类风湿关节炎患者IL-17表达的影响 被引量:7

Regulation of cyclosporin A and methotrexate on IL-17expression in the treatment of rheumatoid arthritis
在线阅读 下载PDF
导出
摘要 目的:研究环孢素A(ciclosporin A,CsA)联合甲氨蝶呤(methotrexate,MTX)治疗对类风湿关节炎(rheumatoid arthritis,RA)患者血清IL-17的表达影响,揭示CsA联合MTX治疗RA的作用机制。方法:收集83例RA经MTX单药或联合CsA治疗的新确诊患者,以及健康志愿者31例。MTX单药治疗组(41例)每周予以MTX(10~15 mg);CsA联合MTX治疗组42例,予以CsA 3 mg/kg/d和MTX(10~15 mg)每周1次;观察和评价患者治疗3月后血清中IL-17的表达变化,以及与疾病活动度评分、RF、anti-CCP之间的关系。结果:两组RA患者治疗前血清IL-17表达均显著高于正常健康对照组(P〈0.001)。与治疗前相比,两组血清中IL-17表达均下降,但MTX单药治疗组无差异性(P=0.062),联合治疗组中IL-17表达显著性下降(P=0.016)。在MTX和CsA联合治疗组中,IL-17的变化值与anti-CCP(r=0.42,P=0.041)和DAS28(r=0.49,P=0.023)的变化值具有相关性。结论:CsA联合MTX治疗RA的机制与抑制IL-17的表达有一定关系。 Objective: To investigate the role of cyclosporin A (CsA) and methotrexate (MTX) combined therapy in modulation of serum IL-17 express in the patients with rheumatoid arthritis (RA).Methods: 83 new patients with rheumatoid arthritis were collected, which consist of MTX monotherapy (41 cases) and combination of MTX and CsA therapy (42 cases). hTe MTX dose was applied for 10~15 mg per week, and CsA was 3 mg/kg per day. hTe sera IL-17 expression was detected by ELISA before therapy and atfer 3 months treatment. In addition, disease activity index, RF and anti-CCP were also evaluated, and corelation between IL-17 and above clinical parameters were analyzed.Results:hTe levels of IL-17 in AR patients and healthy volunteers were analyzed. As compared with healthy control, AR patients have high level of IL-17 (P〈0.001), two group AR patients has no difference. Interestingly, when compared with pre-treatment, the expression of IL-17 was signiifcantly decreased in AR patients with MTX and CsA treatment (P=0.016), while MTX monotherapy has no considerable change (P=0.062). In the MTX and CsA treated group, correlations between the difference of IL-17 and those of clinical 〈br〉 and laboratory parameters at baseline and 3 months from initial treatment showed significant correlation with anti-CCP (r=0.42,P=0.041) and DAS28 (r=0.49,P=0.023).Conclusion:The mechanism of CsA and MTX combined therapy in the patients with rheumatoid arthritis might due to the inhibition of IL-17 expression.
出处 《临床与病理杂志》 CAS 2015年第8期1533-1536,共4页 Journal of Clinical and Pathological Research
关键词 类风湿关节炎 环孢素A 甲氨蝶呤 IL-17 rheumatoid arthritis cyclosporin A methotrexate IL-17
  • 相关文献

参考文献13

  • 1Goodman SM, Cronstein BN, Bykerk VP. Outcomes related to methotrexate dose and route of administration in patients with rheumatoid arthritis: a systematic literature review[J]. Clin Exp Rheumatol, 2015, 33(2): 272-278.
  • 2Lubberts E. The IL-23-IL-17 axis in inflammatory arthritis[J]. Nat Rev Rheumatol, 2015, 11(7): 415-429.
  • 3Stockinger B, Veldhoen M. Differentiation and function of Th17 T cells[J]. Curr Opin Immunol, 2007, 19(3): 281-286.
  • 4Azizi G, Jadidi-Niaragh F, Mirshafiey A. Thl7 Cells in Immunopathogenesis and treatment of rheumatoid arthritis[J]. Int J Rheum Dis, 2013, 16(3): 243-253.
  • 5Goodman SM. Rheumatoid arthritis: Perioperative management of biologics and DMARDs[J]. Semin Arthritis Rheum, 2015, 44(6): 627-632.
  • 6Gremese E, Ferraccioli GF. Benefit/risk of cyclosporine in rheumatoid arthritis[J]. Clin Exp Rheumatol, 2004, 22(5 Supp135): S 101-S 107.
  • 7Miossec P. Rheumatoid arthritis in 2013. Translational medicine in RA: time for change[J]. Nat Rev Rheumatol, 2014, 10(2): 74-76.
  • 8Sarzi-Puttini P, D'Ingianna E, Fumagalli M, et al. An open, randomized comparison study of cyclosporine A, cyclosporine A + methotrexate and cyclosporine A + hydroxychloroquine in the treatment of early severe rheumatoid arthritis[J]. Rheumatol Int, 2005, 25 ( 1): 1 S-22.
  • 9Song X, Gao H, Q ian Y. Thl7 differentiation and their pro- inflammation function[J]. Adv Exp Med Biot, 2014, 841: 99-151.
  • 10Sarkar S, Fox DA. Targeting IL-17 and Thl7 cells in rheumatoid arthritis [ J]. Rheum Dis Clin North Am, 2010, 36 (2): 345-366.

同被引文献75

引证文献7

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部